A derivative-phase CsPb₂Br₅ is introduced into inorganic perovskite solar cells, which will effectively eliminate interface defects, lower the energy barrier of electron transport layer and suppress the recombination at the interface of hole transport layer in the devices.
No takes yet. Share an insight, caveat, or question.
Li et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: